Cognitive-behavioural Treatment of Chronic Back Pain

Study to Compare a Cognitive-behavioral Treatment With a Cognitive-behavioral Treatment With Biofeedback Elements to Patients With Chronic (Low) Back Pain

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00454064

Enrollment

128

Registered

2007-03-29

Start date

2004-09-30

Completion date

2008-02-29

Last updated

2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain

Keywords

cognitive-behavioral therapy, back pain, low back pain, biofeedback, randomized controlled study, EMG biofeedback

Brief summary

The purpose of the study: * to compare two cognitive-behavioral treatments

Detailed description

128 patients suffering from chronic back pain were randomly assigned to either Wait List Control, Cognitive Behavioral Treatment or Cognitive Behavioral Treatment and Biofeedback. Measures were conducted 6 months before treatment (Wait List Control) immediately before and after treatment and at 6-months follow-up. 25 weekly 1-hr sessions of individualized outpatient cognitive behavioral treatment of chronic back pain Treatment elements: Cognitive treatment: identification, evaluation and correction of dysfunctional beliefs about themselves and pain by cognitive restructuring, problem-solving training and coping skills training Behavioural treatment: increasing activity levels (sports, social activities, work), reducing medication intake and unnecessary health care utilization Relaxation training: progressive muscle relaxation, biofeedback.

Interventions

BEHAVIORALcognitive-behavioral treatment

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Back pain since 6 months

Exclusion criteria

* Patients with psychosis, borderline psychopathy, drug dependence i.e. alcohol

Design outcomes

Primary

Measure	Time frame
pain intensity	start of treatment, end of treatment, 6-months follow-up

Secondary

Measure	Time frame
pain disability	start of treatment, end of treatment, 6-months follow-up
depression	start of treatment, end of treatment, 6-months folow-up

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026